Mrs. Mercedes Bertotto | Organic Chemistry | Women Researcher Award

Posted on by sciencefather

Mrs. Mercedes Bertotto | Organic Chemistry | Women Researcher Award

Mrs. Mercedes Bertotto , Organic Chemistry , Researcher in Chemometrics at Wageningen University & Research , Netherlands

Dr. Mercedes Bertotto is a distinguished chemical engineer and food scientist with over 12 years of specialized experience in spectroscopic techniques, chemometrics, and quality control. Based in The Netherlands, she is currently a lecturer at Wittenborg University of Applied Sciences and founder of Vibralytics.nl, promoting sustainable and data-driven innovations in the agri-food sector. Previously, she was a researcher at Wageningen Food and Biobased Research, where she led spectral sensing projects integrating NIR, MIR, and Raman spectroscopy with machine learning. Her earlier role at SENASA, Argentina’s National Reference Laboratory, showcased her leadership in GC-MS residue analysis and chemometric modeling. Fluent in English, Spanish, and Dutch, Dr. Bertotto bridges scientific excellence with cross-cultural communication, driving sustainable solutions in food safety and circular materials. Her contributions to academia, research, and entrepreneurship reflect a strong commitment to innovation, international collaboration, and applied chemical sciences.

Professional Profile : 

Orcid

Scopus 

Summary of Suitability for Award:

Dr. Mercedes Bertotto stands out as an exceptionally qualified candidate for the “Women Researcher Award” due to her profound scientific expertise, leadership, and innovation across multiple sectors. With a Doctorate in Chemical Engineering and a strong academic foundation in Food Science and Technology, she exemplifies excellence in applied and theoretical research. Her 12+ years of impactful work—from Argentina’s SENASA National Reference Laboratory to the Netherlands’ Wageningen Food and Biobased Research—reflect her global research footprint. She has made significant contributions in spectral sensing, chemometrics, machine learning, and food quality control. Moreover, her entrepreneurial initiative as the founder and CEO of Vibralytics.nl demonstrates her commitment to translating science into real-world, sustainable solutions. Dr. Mercedes Bertotto is highly suitable for the “Women Researcher Award’. Her multidisciplinary achievements, pioneering role in spectral analytics, dedication to sustainable food systems, and entrepreneurial leadership in a male-dominated field exemplify the qualities the award seeks to recognize. Her career reflects not only scientific merit but also her inspirational impact as a woman in science, making her a deserving and empowering candidate for this honor.

🎓Education:

Dr. Bertotto holds a Doctorate in Chemical Engineering from the University of Buenos Aires, where her thesis focused on modeling drying and tempering processes of rice (IRGA 424). Her research included dynamic mechanical analysis and mathematical modeling of glass transition temperature, achieving an outstanding score of 10/10. She also holds a Master’s in Food Science and Technology from the Faculty of Pharmacy and Biochemistry, University of Buenos Aires. Her academic formation enabled her to work on food preservation, quality control, and raw material analysis using both physical and chemical techniques. Her educational foundation is rooted in experimental precision, mathematical rigor, and industrial application. This robust background has allowed her to seamlessly bridge theory with practical laboratory and industry-based problem-solving. Her education reflects interdisciplinary training, combining engineering, food science, and analytical chemistry—providing her with the ideal base for impactful research in sustainable biobased materials and food safety.

🏢Work Experience:

Dr. Bertotto brings an extensive and diverse professional background. She currently lectures in Information Management and Data Analytics at Wittenborg University and leads Vibralytics.nl, a company pioneering AI-driven spectroscopy for agri-food applications. Between 2022–2024, she was a spectral sensing researcher at Wageningen Food and Biobased Research, using hyperspectral imaging and chemometrics (PCA, PLS, CNN) for quality control. From 2010 to 2022, she worked at SENASA in Argentina, specializing in NIR/FTIR microscopy, GC-MS, and regulatory compliance in food safety. As a university professor, she taught chemometric tools for doctoral candidates, and she also served as a consultant at SoftLab, contributing to petroleum industry applications of NIR. Her expertise encompasses spectroscopy hardware (Specim FX10/17, MicroNIR, LabSpec), data tools (R, MATLAB), and AI-based modeling. This blend of research, teaching, and consulting makes her a well-rounded scientist, with real-world and academic impact across multiple industries.

🏅Awards: 

While specific awards are not explicitly listed, Dr. Mercedes Bertotto’s recognitions include multiple peer-reviewed publications, oral and poster presentations at prestigious conferences, and leadership roles in top-tier research institutions like Wageningen University. Her work was accepted for presentation at the 38th EFFoST International Conference (2024) and ICNIRS 2023, both internationally acclaimed events in food science and spectroscopy. She has also contributed to publicly recognized innovation efforts in Argentina, featured in national science communications (e.g., Argentina.gob.ar and API-Portal). Her appointment as a doctoral-level professor and selection as a founder and CEO of a research-driven company demonstrates academic and entrepreneurial recognition. Moreover, her trilingual fluency and international engagement serve as indicators of her global scientific outreach and influence. These distinctions—academic, institutional, and professional—reflect her commitment to innovation, research excellence, and interdisciplinary problem-solving in chemical engineering and food safety.

🔬Research Focus:

Dr. Bertotto’s research is grounded in analytical chemistry, spectral sensing, and chemometric modeling applied to food and agricultural systems. Her focus lies in leveraging Near-Infrared (NIR), Mid-Infrared (MIR), FTIR microscopy, Raman spectroscopy, and gas chromatography-mass spectrometry (GC-MS) to improve food quality, detect contaminants, and enable circular and sustainable material flows. She specializes in multivariate analysis (PCA, PLS-DA, ANN, CNN) for interpreting complex spectral data in real-time monitoring systems. Her work integrates hyperspectral imaging with AI-driven tools to predict physical and chemical properties of biological materials, such as fungal susceptibility in tomatoes or nutrient profiling in dairy. She is also deeply involved in modeling moisture and thermal behavior in grains like rice. Her research bridges fundamental science with applied industry solutions—creating novel analytical frameworks that optimize safety, quality, and sustainability in bio-based materials, food systems, and environmental monitoring.

Publication Top Notes:

1. Predicting fungal infection sensitivity of sepals in harvested tomatoes using imaging spectroscopy and partial least squares discriminant analysis

2. Comparison between Chemometrics and Machine Learning for the Prediction of Macronutrients in Fresh Cheeses Using Imaging Spectroscopy

3. Detection of Animal By‑Products in Bone Ashes by Near Infrared Spectroscopy Coupled with Microscopy

  citation : 1

 

 

Dr. Qunfeng Luo | Organic Chemistry | Best Researcher Award

Posted on by sciencefather

Dr. Qunfeng Luo | Organic Chemistry | Best Researcher Award

Dr. Qunfeng Luo , Organic Chemistry ,  Nanchang University, China

Dr. Qunfeng Luo is a dedicated Lecturer at the School of Basic Medical Sciences, Nanchang University, China. With a robust background in organic synthesis and protein chemistry, his research explores innovative approaches in peptide/protein modification and bioorthogonal chemistry. Dr. Luo has made notable contributions to the development of multifunctional bioconjugation reagents and mitochondrion-targeting molecules, with publications featured in top-tier journals like Nature Communications and Organic Letters. He earned his Ph.D. from Nanjing University and has held research positions at prestigious institutions, including Northwestern Polytechnical University. Dr. Luo also brings industry experience from Pharmaron (Ningbo) New Pharmaceutical Technology Co., Ltd. His work bridges chemical biology and therapeutic discovery, particularly focusing on functional biomolecule engineering and natural active ingredient target identification. A proactive researcher with an ORCID profile, he continues to advance translational biomedical science through interdisciplinary innovations.

Professional Profile : 

Orcid

Scopus

Summary of Suitability for Award:

Dr. Luo has demonstrated a solid and progressive academic background, holding a Ph.D. from Nanjing University and postdoctoral experience in both academia and industry. His education from top Chinese institutions equips him with a multidisciplinary foundation in biomedical and pharmaceutical sciences.His research has been published in top-tier journals such as Nature Communications, Organic Letters, and RSC Advances. Notably, his 2019 Nature Communications paper was highlighted in Synfacts, indicating significant recognition in the global scientific community. Dr. Luo’s work spans organic synthesis, peptide/protein modification, mitochondrion-targeting agents, and bioorthogonal chemistry. Dr. Luo has maintained a consistent output of quality research with a clear upward trajectory in the complexity and impact of his work. His continued research activity, mentorship, and involvement in academia strengthen his candidacy. Dr. Qunfeng Luo is a highly suitable candidate for the “Best Researcher Award”. His impactful publications, innovative methodologies in chemical biology, and contributions to targeted therapeutics and diagnostics reflect the qualities sought in a top-tier researcher. His unique blend of academic excellence, industrial insight, and interdisciplinary work makes him not only a prolific scientist but also a future leader in biomedical research. Recognizing Dr. Luo with this award would be both timely and well-deserved.

🎓Education:

Dr. Qunfeng Luo’s academic journey reflects a strong foundation in medical and pharmaceutical sciences. He began his higher education at Harbin Medical University (2005.9–2010.6), where he gained essential knowledge in medical sciences. Building upon this, he pursued a master’s degree at China Pharmaceutical University (2011.9–2014.6), developing a solid base in drug design and bioactive compound synthesis. Driven by a keen interest in chemical biology and therapeutic research, he advanced to Nanjing University (2014.9–2018.12) for his doctoral studies. There, he specialized in organic synthesis and protein/peptide bioconjugation techniques, which laid the groundwork for his current research in bio orthogonal chemistry and target identification. This comprehensive academic training, combining medical, pharmaceutical, and chemical expertise, enables Dr. Luo to contribute significantly to multidisciplinary biomedical research.

🏢Work Experience:

Dr. Qunfeng Luo has held diverse academic and industry positions, enriching his expertise in biomedical sciences. He began his professional journey at Pharmaron (Ningbo) New Pharmaceutical Technology Co., Ltd. (2019.3–2019.9), gaining valuable experience in pharmaceutical R&D. He then transitioned to academia as a research fellow at Northwestern Polytechnical University (2019.9–2020.10), focusing on bioorganic chemistry and molecular modification. Since October 2020, he has served as a Lecturer at the School of Basic Medical Sciences, Nanchang University, where he leads research in peptide modification, mitochondrion-targeting molecules, and functional bioconjugation reagents. Dr. Luo’s balanced experience across academia and industry fosters a translational approach to his research, bridging synthetic chemistry and medical application. His current academic role involves not only high-impact research but also mentoring students and contributing to the university’s biomedical education initiatives.

🏅Awards: 

While specific honors were not detailed, Dr. Qunfeng Luo’s research achievements speak volumes of his recognition in the scientific community. His 2019 Nature Communications publication was highlighted in Synfacts, indicating significant impact in the field of synthetic and chemical biology. Publishing in top-tier journals like Organic Letters and RSC Advances also reflects the high regard in which his work is held. As a young scholar with an innovative portfolio in bioorthogonal chemistry, peptide/protein modification, and mitochondrion-targeting agents, Dr. Luo is well-positioned for future awards and funding opportunities. His diverse background, including experience in pharmaceutical R&D and academia, contributes to his growing influence in biomedical research. As he continues to contribute to high-impact projects and interdisciplinary science, further accolades are expected.

🔬Research Focus:

Dr. Qunfeng Luo’s research lies at the intersection of organic chemistry and biomedical sciences. His primary interests include organic synthesis, peptide and protein modification, and bioorthogonal chemistry—innovative fields that enable precise molecular labeling and therapeutic design. A major focus of his work is developing heterobifunctional cross-linkers that facilitate selective bioconjugation, peptide stapling, and mitochondrial targeting. He also explores target identification of natural active ingredients, contributing to drug discovery and understanding bioactivity mechanisms. His recent publications reveal an emphasis on multifunctional bioconjugation reagents with broad applications in diagnostics and targeted therapies. The integration of small molecule design with functional biomolecules positions his research within both fundamental and translational biomedical innovation. Through interdisciplinary collaborations and advanced chemical techniques, Dr. Luo’s work contributes to the development of precision tools for chemical biology and therapeutic interventions.

Publication Top Notes:

1. Heterobifunctional Cross-Linker with Dinitroimidazole and Azide Modules for Protein and Oligonucleotide Functionalization

2. Heterobifunctional Cross-Linker with Dinitroimidazole and N-Hydroxysuccinimide Ester Motifs for Protein Functionalization and Cysteine–Lysine Peptide Stapling

3. Combination Therapies against COVID-19

4. Dichloroacetophenone Derivatives: A Class of Bioconjugation Reagents for Disulfide Bridging

5. Dinitroimidazoles as Bifunctional Bioconjugation Reagents for Protein Functionalization and Peptide Macrocyclization

6. Recent Advances in Enone and NO-Releasing Derivatives of Oleanolic Acid with Anti-cancer Activity

 

 

Mr. Yong-Feng Cheng | Organic Chemistry | Best Researcher Award

Posted on by sciencefather

Mr. Yong-Feng Cheng | Organic Chemistry | Best Researcher Award

Mr. Yong-Feng Cheng , Organic Chemistry, Anhui Normal University, China

Dr. Yong-Feng Cheng is an Associate Professor at the School of Chemistry and Materials Science, Anhui Normal University, China. He is a leading researcher in the field of radical chemistry and enantioselective catalysis. After earning his Ph.D. in Organic Chemistry from Nankai University, he pursued postdoctoral and faculty roles at the Southern University of Science and Technology, where he made significant contributions to copper-catalyzed asymmetric transformations. Dr. Cheng’s research, published in prestigious journals such as Nature Chemistry, JACS, and Nature Catalysis, emphasizes radical-based bond-forming reactions and novel catalytic systems. With a solid background in pharmacy and pharmaceutical analysis, he bridges organic synthesis with potential bioactive molecule development. His work is characterized by mechanistic insight, innovation in catalyst design, and collaboration with renowned scientists like Prof. X. Liu and Prof. K.N. Houk. Dr. Cheng continues to push boundaries in modern synthetic chemistry, mentoring students and contributing to cutting-edge discoveries.

Professional Profile :         

Orcid

Scopus  

Summary of Suitability for Award:

Assoc. Prof. Yong-Feng Cheng stands out as a highly suitable candidate for the “Best Researcher Award” . Based on his exceptional publication record, breakthrough contributions to enantioselective radical chemistry, rapid career advancement, and international collaboration, Assoc. Prof. Yong-Feng Cheng is highly deserving of the “Best Researcher Award.” His work reflects a balance of innovation, depth, and scientific rigor, and he has already made a significant mark in modern synthetic chemistry. Granting him this recognition would not only honor a deserving candidate but also inspire broader excellence in chemical sciences.

🎓Education:

Yong-Feng Cheng began his academic journey with a Bachelor’s degree in Pharmacy from Wannan Medical College (2005–2009). Motivated by a strong interest in the analytical and chemical aspects of drug development, he pursued a Master of Science in Pharmaceutical Analysis at Tianjin University of Traditional Chinese Medicine (2009–2012). His growing passion for organic synthesis led him to Nankai University, where he earned his Ph.D. in Organic Chemistry (2012–2015). At Nankai, he specialized in developing synthetic methodologies and advanced radical transformations. His doctoral training laid a solid foundation for his future work in radical catalysis. With this multidisciplinary education—spanning pharmacy, analytical science, and organic chemistry—Dr. Cheng brings a uniquely integrated perspective to the development of functional molecules and asymmetric synthesis. His academic background enables him to innovate at the intersection of fundamental chemistry and potential therapeutic applications.

🏢Work Experience:

Dr. Yong-Feng Cheng has steadily advanced through competitive academic roles in China’s premier institutions. From 2016 to 2018, he worked as a postdoctoral fellow at the Southern University of Science and Technology (SUSTech), collaborating on pioneering research in enantioselective radical transformations. Recognized for his innovative approach, he was promoted to Research Assistant Professor at SUSTech (2018–2022), where he co-authored several high-impact papers and contributed significantly to catalyst development. In 2023, he joined Anhui Normal University as an Associate Professor in the School of Chemistry and Materials Science. His current role involves leading a research group focused on asymmetric catalysis, mentoring graduate students, and securing national research grants. With a blend of research acumen and teaching excellence, Dr. Cheng continues to shape the future of synthetic chemistry, integrating his deep understanding of radicals, catalysis, and reaction mechanisms across disciplines.

🏅Awards: 

While the specific awards and honors of Dr. Yong-Feng Cheng are not explicitly listed, his track record of publishing in journals like Nature Chemistry, JACS, and Angewandte Chemie reflects high recognition in the international scientific community. Being co-first and corresponding author in several high-impact papers demonstrates peer acknowledgment of his leading role in radical catalysis. His research collaborations with globally renowned scientists like Prof. K.N. Houk and Prof. X. Liu further validate his standing as an innovative researcher. His rapid career progression—from Ph.D. to Associate Professor in under a decade—is itself a testimony to his scientific excellence. He has likely received institutional recognition for teaching and research performance and may have earned national-level research grants or young scientist accolades. As his work continues to draw citations and attention, more formal honors are anticipated in the near future.

🔬Research Focus:

Dr. Yong-Feng Cheng’s research is centered on enantioselective radical transformations, with a focus on copper-catalyzed asymmetric reactions. His work explores the interface of Organic chemistry and catalysis, developing novel methodologies for constructing C–O, S–O, and C–C bonds with high stereo control. His synthetic strategies employ innovative ligand systems and cooperative catalysis to achieve de- symmetrization and functionalization of otherwise inert molecules. Dr. Cheng has contributed significantly to the design of catalytic systems that enable precise manipulation of reactive radical intermediates, with potential applications in pharmaceuticals, agrochemicals, and material science. He is particularly interested in mechanistic insights, transition-state modeling, and computational collaboration to understand catalytic pathways. With a strong background in both pharmacy and organic synthesis, Dr. Cheng’s research is both methodologically rigorous and application-oriented. His group continues to develop sustainable and scalable reactions for asymmetric synthesis, including redox-triggered transformations and metal-catalyzed coupling strategies.

Publication Top Notes:

1. A P‐nucleophile Interrupted Seyferth‐Gilbert Reaction​

2. Synthesis of Axially Chiral Vinyl Halides via Cu(I)-Catalyzed Enantioselective Radical 1,2-Halofunctionalization of Terminal Alkynes

3. Cu(I)-Catalyzed Chemo- and Enantioselective Desymmetrizing C–O Bond Coupling of Acyl Radicals

4. Cu-Catalyzed Enantioselective Radical Heteroatomic S–O Cross-Coupling

5. Catalytic Enantioselective Desymmetrizing Functionalization of Alkyl Radicals via Cu(I)/CPA Cooperative Catalysis​

6. Desymmetrization of Unactivated Bis-Alkenes via Chiral Brønsted Acid-Catalyzed Hydroamination​

7. Achiral Pyridine Ligand-Enabled Enantioselective Radical Oxytrifluoromethylation of Alkenes with Alcohols​

8. Synthesis of γ-Lactams by Mild, o-Benzoquinone-Induced Oxidation of Pyrrolidines Containing Oxidation-Sensitive Functional Groups​

9. Redox-Triggered α-C–H Functionalization of Pyrrolidines: Synthesis of Unsymmetrically 2,5-Disubstituted Pyrrolidines​

10. A New Practical Approach Towards the Synthesis of Unsymmetric and Symmetric 1,10-Phenanthroline Derivatives at Room Temperature

 

Dr. Ji-Wei Ren | Organic Chemistry | Best Researcher Award

Posted on by sciencefather

Dr. Ji-Wei Ren | Organic Chemistry | Best Researcher Award

Dr. Ji-Wei Ren, Organic Chemistry, Taishan University , China 

Dr. Ji-Wei Ren is a Lecturer in the College of Chemistry and Chemical Engineering at Taishan University, China. He earned his Ph.D. in Chemical Engineering and Technology from Central South University, where he developed expertise in visible light catalysis, organo catalysis, and green synthesis. Dr. Ren has previously served as a Research Associate at Ningbo University’s Institute of Drug Discovery Technology, engaging in interdisciplinary research on biomimetic reducing agents and chiral resolution. With a strong foundation in heterocyclic construction and peptide synthesis, his work integrates sustainable and biomimetic chemistry with modern synthetic methodologies. Dr. Ren has published multiple high-impact research articles in leading journals such as Org. Lett., J. Org. Chem., and Org. Chem. Front.. His research is characterized by innovation, precision, and relevance to both pharmaceutical and materials chemistry. He actively contributes to academic platforms like ORCID and collaborates with renowned scientists across China.

Professional Profile :         

Orcid

Scopus 

Summary of Suitability for Award:

Dr. Ji-Wei Ren exemplifies the qualities of an outstanding researcher through his pioneering work in the field of organic synthesis, particularly in visible light catalysis, organocatalysis, and green chemistry. He has published over 11 peer-reviewed articles in top-tier journals such as Organic Chemistry Frontiers, Journal of Organic Chemistry, Organic Letters, and Chemistry – A European Journal. Several of his works have been highlighted by Synfacts, showcasing their novelty and scientific impact. His innovative contributions include the development of racemization-free synthesis protocols, the application of biomimetic reducing agents, and the design of sustainable methodologies for heterocycle and peptide construction. He brings a fresh perspective to traditional synthetic methods by incorporating visible light and bio-inspired techniques, addressing both the efficiency and environmental responsibility in chemical synthesis. Dr. Ji-Wei Ren is highly suitable for the “Best Researcher Award”. His significant scientific output, innovation in research, recognition by the international community, and dedication to sustainable chemistry clearly distinguish him as a leading researcher in his field. His commitment to impactful and environmentally conscious science makes him not only an excellent candidate but also a role model for emerging researchers. This award would be a deserving recognition of his ongoing contributions to the scientific world.

🎓Education:

Dr. Ji-Wei Ren completed both his undergraduate and doctoral studies at Central South University. He earned his Bachelor of Engineering in Pharmaceutical Engineering in June 2013, where he gained foundational knowledge in pharmaceutical chemistry, drug design, and synthesis. Subsequently, he pursued a Doctorate in Chemical Engineering and Technology (2013–2019) at the same university. His Ph.D. research focused on innovative synthetic strategies using organo catalysis and visible-light-driven methodologies for the construction of functional molecules, especially in the development of peptide and heterocyclic compounds. Under the mentorship of distinguished faculty, he honed his skills in reaction design, stereoselective synthesis, and catalysis. His academic training also included a deep understanding of biomimetic reactions, green synthesis, and photochemical transformations. This robust educational background laid the groundwork for his interdisciplinary research efforts, enabling him to contribute significantly to the fields of sustainable and asymmetric synthesis.

🏢Work Experience:

Dr. Ji-Wei Ren began his academic career as a Research Associate (2019–2022) at the Institute of Drug Discovery Technology, Ningbo University, where he focused on peptide synthesis and the development of bio-inspired reducing agents. His role involved collaborative projects in pharmaceutical chemistry and catalysis, contributing to the advancement of efficient and eco-friendly synthetic methods. In August 2022, he joined Taishan University as a Lecturer in the College of Chemistry and Chemical Engineering. At Taishan University, Dr. Ren continues his research in visible light catalysis and organocatalytic transformations, guiding students in advanced organic chemistry techniques and experimental methodologies. He has also contributed to curriculum development and interdisciplinary research programs. His teaching and research philosophy is rooted in innovation, sustainability, and student engagement. With over a decade of academic training and research, Dr. Ren combines a strong theoretical foundation with hands-on experience in both industrial and academic labs.

🏅Awards: 

Dr. Ji-Wei Ren has been consistently recognized for his impactful contributions to organic chemistry and green synthesis methodologies. His 2021 publication in Organic Letters was highlighted by Synfacts in 2022 for its innovative racemization-free synthesis approach, underlining the originality and practical importance of his work. Additionally, his earlier work in The Journal of Organic Chemistry (2017) was also spotlighted in Synfacts, reflecting his ongoing excellence in visible light-mediated and organocatalytic transformations. During his doctoral studies at Central South University, he was honored with multiple academic excellence awards for his outstanding research and scholarly dedication. His publications in top-tier journals like Organic Chemistry Frontiers, Organic & Biomolecular Chemistry, and Chemistry – A European Journal have further established him as a rising expert in his field. These recognitions underscore both the scientific value and the practical applicability of his research in modern organic synthesis.

🔬Research Focus:

Dr. Ji-Wei Ren’s research is centered on the development of innovative, environmentally friendly methodologies in organic synthesis. His primary interests lie in visible light catalysis, where he designs photochemical processes to enable mild and selective transformations. He is also deeply involved in chiral resolution and organocatalysis, with a particular emphasis on enantioselective reactions that are crucial for pharmaceutical synthesis. A significant part of his work involves constructing complex heterocyclic compounds, often using biomimetic and green synthesis strategies to reduce environmental impact. Dr. Ren has pioneered the use of L-amino acid esters as biomimetic reducing agents and introduced new deoxygenation and amidation protocols that avoid racemization—critical for peptide and amide bond formation. His interdisciplinary approach blends traditional organic chemistry with sustainability, aiming to create scalable, efficient, and selective processes suitable for industrial application. His contributions significantly enhance both academic understanding and practical implementation in organic synthesis.

Publication Top Notes:

“A visible light-mediated deoxygenation protocol for the synthesis of dipeptides, amides and esters without racemization”​

“L-Amino acid ester as a biomimetic reducing agent for the reduction of unsaturated C=C bonds”

“Umpolung Strategy for the One-Pot Synthesis of Highly Steric Bispirooxindoles via the L-Amino Acid Ester-Promoted In Situ Reduction/Nucleophilic Addition/Cyclization Cascade Reaction”​

“A visible light-induced deoxygenative amidation protocol for the synthesis of dipeptides and amides”​

“An organocatalytic enantioselective ring-reorganization domino sequence of methyleneindolinones with 2-aminomalonates”​

“Straightforward Synthesis of 3-Selenocyanato-Substituted Chromones through Electrophilic Selenocyanation of Enaminones under Grinding Conditions”​

“Organocatalytic, Enantioselective, Polarity-Matched Ring-Reorganization Domino Sequence Based on the 3-Oxindole Scaffold”

“A One‐Pot Ring‐Opening/Ring‐Closure Sequence for the Synthesis of Polycyclic Spirooxindoles”​

“L-Pyroglutamic Sulphonamide as Hydrogen-Bonding Organocatalyst: Enantioselective Diels–Alder Cyclization to Construct Carbazolespirooxindoles”

“Acid-Relayed Organocatalytic exo-Diels-Alder Cycloaddition of Cyclic Enones with 2-Vinyl-1H-indoles”

 

Ms. Apurva Singh | Organic Chemistry | Best Researcher Award

Posted on by sciencefather

Ms. Apurva Singh | Organic Chemistry | Best Researcher Award

Ms. Apurva Singh | Organic Chemistry | PhD at Indian institute of technology Roorkee, India

Apurva Singh is an organic chemistry  with a keen interest in technological advancements and artificial intelligence applications in chemistry. With five years of research experience in academic laboratories and two years as a tutor, she specializes in organic synthesis and catalysis. Currently pursuing her Ph.D. at IIT Roorkee under Prof. Naseem Ahmed, she is engaged in process chemistry, exploring new methodologies using homogeneous and heterogeneous catalysis. Apurva has a strong publication record in international journals, reflecting her expertise and dedication to scientific research. She is highly motivated, analytical, and committed to knowledge exchange. Her enthusiasm for teaching, research, and interdisciplinary collaboration makes her a dynamic professional in the field of chemistry.

Professional Profile : 

Orcid

Scopus 

Summary of Suitability for Award:

Apurva Singh is a highly promising researcher in the field of organic synthesis and catalysis, demonstrating a strong commitment to scientific innovation. With five years of research experience at IIT Roorkee, she has contributed significantly to the development of novel catalytic methodologies, particularly in transition-metal catalysis, oxidation reactions, and organo catalysis. Her research has led to multiple publications in high-impact journals, including RSC, Synthesis (Thieme), and Organic & Biomolecular Chemistry, showcasing her ability to conduct impactful studies. Additionally, she has received prestigious poster awards at national and international conferences, underscoring her ability to effectively present and communicate her findings. Given her strong publication record, innovative research contributions, and recognition through awards, Apurva Singh is a highly suitable candidate for the “Best Researcher Award.” Her work in catalysis and organic synthesis, coupled with her dedication to advancing chemical sciences, makes her a deserving nominee for this prestigious recognition.

🎓Education:

Apurva Singh is currently pursuing her Ph.D. in Organic Synthesis and Catalysis at the Indian Institute of Technology (IIT) Roorkee under the mentorship of Prof. Naseem Ahmed. Her research focuses on developing innovative catalytic methodologies for organic transformations, with publications in reputed journals such as RSC and Synthesis (Thieme). Prior to her Ph.D., she completed her Master of Science (M.Sc.) in Chemistry from Chaudhary Charan Singh University (CCSU), Meerut, in 2017, securing a first-class distinction with 76%. During her postgraduate studies, she gained expertise in organic chemistry and reaction mechanisms, further strengthening her foundation in the subject. Additionally, she pursued a Bachelor of Education (B.Ed.) from CCSU, Meerut, from 2018 to 2020, achieving 80%. Her B.Ed. degree equipped her with essential teaching skills, enhancing her ability to mentor and guide students in the academic field. Apurva’s strong academic background demonstrates her dedication to both research and education.

🏢Work Experience:

Apurva Singh has over five years of research experience in organic chemistry, specializing in catalysis, and two years of teaching experience. She is currently a Ph.D. researcher at IIT Roorkee, working on process chemistry, where she investigates novel catalytic methodologies for organic synthesis. Her research involves designing transition-metal complexes for oxidation reactions and developing regio selective synthetic strategies. She has published multiple research articles in internationally recognized journals, highlighting her contributions to the field. Apart from research, she has two years of experience as an academic tutor, mentoring undergraduate and postgraduate students in organic chemistry. She has assisted in research activities, manuscript writing, and conference presentations. Her expertise extends to coding for computational chemistry applications, bridging experimental and theoretical approaches. Apurva’s proactive nature and strong communication skills enable her to collaborate effectively, making significant contributions to both research and academic training.

🏅Awards: 

Apurva Singh has received multiple accolades for her outstanding research contributions. In 2024, she was awarded the Poster Award at the Indian Academy of Sciences Meeting and Lecture Workshop held at IIT Roorkee, recognizing her innovative work in catalysis and organic synthesis. In the same year, she won another Poster Award at the 2nd International Conference on Molecules to Materials at NIT Hamirpur, further establishing her expertise in the field. These awards highlight her ability to present complex scientific findings effectively and her dedication to advancing research. Her work has been widely appreciated for its significance in developing new catalytic methodologies, and she continues to be an active participant in scientific conferences and symposiums. Apurva’s achievements reflect her commitment to excellence in research and academia, positioning her as a promising scientist in the field of organic chemistry.

🔬Research Focus:

Apurva Singh’s research focuses on organic synthesis and catalysis, with a strong emphasis on developing novel transition-metal complexes for oxidation reactions. She explores homogeneous and heterogeneous catalysis to improve reaction efficiency and selectivity, mimicking enzymatic processes for sustainable chemistry. Her work includes the design of μ-chlorido-bridged dimanganese(II) complexes to replicate galactose oxidase enzyme activity, offering applications in oxidation and aldol reactions. She is also engaged in Fenton free radical reactions for regio selective synthesis of complex molecules. Her recent studies on organocatalytic synthesis of bioactive pyrazoline and pyrimidine derivatives contribute to medicinal chemistry by targeting bacterial enzymes like thymidine kinase in Staphylococcus aureus. Apurva is particularly interested in the intersection of chemistry and artificial intelligence, leveraging computational tools to predict reaction mechanisms and optimize catalyst design. Her multidisciplinary approach bridges fundamental chemistry with emerging technologies, driving innovation in organic synthesis and process chemistry.

Publication Top Notes:

1. Nickel(II)-hydrazineylpyridine catalyzed regioselective synthesis of α-benzyl substituted β-hydroxy ketones via a Fenton free radical reaction

Authors: Not provided in the given data

Year: 2025

Journal: Organic & Biomolecular Chemistry

2. Oxidative Cyclization Reactions Catalyzed by Designed Transition-Metal Complexes: A New Strategy for the Synthesis of Flavone, Quinolone, and Benzofuran Derivatives

Authors: Not provided in the given data

Year: 2023

Journal: Synthesis

3. Designed μ-Chlorido-bridged dimanganese(II) complexes to mimic the activity of galactose oxidase enzyme: Application in the dehydrogenative oxidation of alcohol and aldol reaction

Authors: Not provided in the given data

4. Organocatalytic synthesis of novel pyrazoline and pyrimidine derivatives as potent thymidine kinase inhibitors targeting Staphylococcus aureus

Authors: M.I. Issa Alahmdi

Year: 2025

 

 

Dr. Hongjian Qin | Organic Chemistry | Best Researcher Award

Posted on by sciencefather

Dr. Hongjian Qin | Organic Chemistry | Best Researcher Award

Dr. Hongjian Qin , Shanghai Institute of Materia Medica, CAS , China

Dr. Hongjian Qin is an accomplished researcher in sustainable and green chemistry, with expertise in drug process development and medicinal administration. He earned his Ph.D. in Organic Chemistry from the Chinese Academy of Sciences, being recognized as an Excellent Graduate in 2024. Dr. Hongjian Qin’s contributions to the field span over three years, emphasizing environmentally friendly pharmaceutical synthesis and active pharmaceutical ingredient (API) development. Currently serving as Research Director at Topharman Company Limited, he continues to advance innovative solutions in drug development. His work includes mentoring students, enhancing resource recovery, and participating in COVID-19 research. With numerous impactful publications, Dr. Hongjian Qin is a dedicated professional committed to promoting sustainability and advancing solutions for global environmental challenges.

Professional Profile:

Scopus 

Summary of Suitability for Award:

Dr. Hongjian Qin is an exemplary candidate for the “Best Researcher Awards,” with a distinguished career in sustainable and green chemistry. His pioneering research in eco-friendly pharmaceutical synthesis has significantly contributed to reducing industrial waste and enhancing process efficiency, aligning with global sustainability objectives. Dr. Hongjian Qin’s innovative work on ligand-free catalysis, large-scale API production, and impurity profiling reflects his expertise in developing practical solutions for complex challenges in organic chemistry and medicinal chemistry. Dr. Hongjian Qin’s research excellence, innovative contributions, and global impact make him a highly deserving candidate for the “Best Researcher Awards.” His work not only addresses critical scientific challenges but also fosters sustainable practices in drug development, making a lasting impact on both academia and industry.

🎓Education:

Dr. Hongjian Qin holds a Ph.D. in Organic Chemistry from the Chinese Academy of Sciences , specializing in process development of drug substances and medicinal administration. His doctoral work was conducted at the Key Laboratory of Plant Resources and Chemistry in Arid Regions, showcasing expertise in sustainable pharmaceutical synthesis. He completed a Master of Engineering in Organic Chemistry from Guangxi University, focusing on the process development of drug substances. Dr. Qin’s academic journey began with a Bachelor of Science in Organic Chemistry from Guangxi University . His educational foundation combines rigorous theoretical knowledge with practical applications, preparing him to address complex challenges in green and sustainable chemistry.

🏢Work Experience:

Dr. Hongjian Qin’s professional journey spans over a decade, focusing on pharmaceutical synthesis and sustainable chemistry. As Research Director at Topharman Company Limited (2024–present), he spearheads innovations in active pharmaceutical ingredients (APIs) and emphasizes good manufacturing practices (GMP). Previously, as a Research Assistant at the Shanghai Institute of Materia Medica (2021–2024), he supported COVID-19 research projects, trained students, and enhanced pharmaceutical waste recovery techniques. At the Xinjiang Engineering Research Centre for Key Technologies and Processes of Ethnomedicine (2015–2021), Dr. Hongjian Qin led projects on sustainable API production and industrial resource recovery. His experiences reflect a blend of academic research and industrial application, driving advancements in pharmaceutical science.

🏅Awards: 

Dr. Hongjian Qin has received numerous accolades for his contributions to sustainable chemistry. He was honored as an Excellent Graduate in 2024 by the University of Chinese Academy of Sciences for his outstanding academic achievements during his Ph.D. studies. His work on sustainable pharmaceutical synthesis earned him recognition at various national and international conferences. Dr. Hongjian Qin has been instrumental in developing innovative processes for drug substances, garnering appreciation from industrial partners. Additionally, his mentorship roles and administrative contributions at research institutions have been commended, underscoring his commitment to advancing science and education.

🔬Research Focus:

Dr. Hongjian Qin’s research focuses on sustainable and green chemistry, particularly in the process development of drug substances. He has worked extensively on optimizing synthesis methods for pharmaceutical intermediates, reducing waste, and improving efficiency in drug manufacturing. His innovative approaches emphasize the use of eco-friendly reagents and catalysts, aligning with global sustainability goals. His recent work includes developing ligand-free copper-catalyzed cyclization methods, novel iron-catalyzed cross-coupling reactions, and efficient large-scale processes for active pharmaceutical ingredients (APIs). Dr. Hongjian Qin is dedicated to advancing environmentally responsible techniques in pharmaceutical synthesis, ensuring both industrial viability and ecological preservation.

Publication Top Notes:

1. Direct Esterification of Amides by the Dimethylsulfate-Mediated Activation of Amide C–N Bonds

Authors: Qin, H.; Han, Z.; Bonku, E.M.; Shen, J.; Aisa, H.A.

Year: 2024

Citations: 0

2. An Alternative Approach to Synthesize Sildenafil via Improved Copper-Catalyzed Cyclization

Authors: Odilov, A.; Gong, X.; Qin, H.; Yang, F.; Shen, J.

Year: 2024

Citations: 0

3. Impurity Study of Tecovirimat (Open Access)

Authors: Bonku, E.M.; Qin, H.; Odilov, A.; Wang, X.; Shen, J.

Year: 2024

Citations: 1

4. Improved and Ligand-Free Copper-Catalyzed Cyclization for an Efficient Synthesis of Benzimidazoles from o-Bromoarylamine and Nitriles (Open Access)

Authors: Bonku, E.M.; Qin, H.; Odilov, A.; Aisa, H.A.; Shen, J.

Year: 2024

Citations: 2

5. Direct Reductive N-Alkylation of Amines with Carboxylic Esters

Authors: Zhang, Y.; Bonku, E.M.; Yang, X.; Shen, J.; Qin, H.

Year: 2024 (In Press)

Citations: 0

6. Iron-Catalyzed Cross-Coupling Reactions of Alkyl Grignard Reagents with Alkenyl Carbonate

Authors: Qin, H.; Yang, X.; Mintah Bonku, E.; Shen, J.; Akber Aisa, H.

Year: 2024 (In Press)

Citations: 0

7. A Review of the Synthetic Strategies Toward the Antiviral Drug Tecovirimat (Review Article)

Authors: Bonku, E.M.; Qin, H.; Odilov, A.; Zhu, F.; Shen, J.

Year: 2024 (In Press)

Citations: 0

8. An Improved Iodine-Catalyzed Aromatization Reaction and Its Application in the Synthesis of a Key Intermediate of Cannabidiol

Authors: Abduahadi, S.; Bonku, E.M.; Qin, H.; Aisa, H.A.; Shen, J.

Year: 2024 (In Press)

Citations: 0

9. Optimized Synthesis of the Key Intermediate of Telmisartan via the Cyclization of 2-Bromoarylamine with n-Butyronitrile

Authors: Qin, H.; Mintah Bonku, E.; Odilov, A.; Zhu, F.; Aisa, H.A.

Year: 2023

Citations: 1

10. Efficient Large-Scale Process for Tecovirimat via Reactive Distillation for the Preparation of Cycloheptatriene

Authors: Bonku, E.M.; Qin, H.; Odilov, A.; Guma, S.D.; Shen, J.

Year: 2023

Citations: 4

 

 

 

 

 

Khalid Khan | Organic Chemistry | Best Researcher Award

Posted on by sciencefather

Assoc Prof Dr. Khalid Khan | Organic Chemistry | Best Researcher Award

Associate Professor at Islamia College University, Peshawar, Pakistan

Dr. Khalid Khan is an accomplished chemist with extensive expertise in organic chemistry and medicinal research. He obtained his PhD from Huazhong University of Science and Technology in China, focusing on the design and synthesis of novel dendro-calix[4]arenes. Currently, he serves as an Associate Professor at Islamia College University in Peshawar, Pakistan, where he leads various research projects and supervises graduate and undergraduate students. His work has significantly contributed to the field of drug discovery, particularly in computational and medicinal chemistry.

Author Metrics

Scopus Profile

Dr. Khan has published over 25 research articles in reputable journals, showcasing his research impact and contribution to the field of chemistry. His work has garnered numerous citations, reflecting the relevance and influence of his research on both national and international platforms. His publication metrics highlight his active engagement in advancing scientific knowledge, particularly in the areas of antiviral drug development and nanotechnology.

  • Citations: 414 citations across 379 documents
  • Documents: 21 published works
  • h-index: 9

Education

Dr. Khan completed his PhD in Chemistry from Huazhong University of Science and Technology, China (2008-2013), where he conducted groundbreaking research on nonionic amphiphilic dendro-calix[4]arenes. He holds a Master’s degree in Chemistry from the University of Peshawar (2002-2004), where he graduated with first-class honors, and a Bachelor’s degree in Biological Science from Government College Peshawar (2000-2002).

Research Focus

Dr. Khan’s research primarily revolves around organic chemistry, with a special focus on the synthesis and characterization of bioactive compounds. He is particularly interested in the development of antiviral agents and the computational modeling of drug interactions with viral proteins. His innovative research projects often explore the structure-activity relationships of compounds to enhance therapeutic efficacy.

Professional Journey

Beginning his career as a lecturer in 2005, Dr. Khan progressively advanced to the role of Associate Professor in 2020 at Islamia College University. Throughout his tenure, he has significantly contributed to the academic environment by designing curricula, supervising research, and engaging in community service. His professional journey is marked by a commitment to education, research, and the development of future scientists.

Honors & Awards

Dr. Khan has received several prestigious awards, including the Pakistan and Chinese Government Cultural Exchange Scholarship for his doctoral studies. He was recognized as the topper in his Master’s program, reflecting his dedication and excellence in the field of chemistry. His achievements have earned him a respected place among his peers in academia.

Publications Noted & Contributions

Among his numerous publications, key works include research on the design and synthesis of novel dendro-calix[4]arenes, antiviral drug development, and the characterization of compounds with potential therapeutic applications. His contributions have advanced understanding in various areas of organic chemistry and nanotechnology, facilitating further research in these domains.

Homology modeling and molecular docking study of metabotropic glutamate receptor 5 variant F: An attempt to develop drugs for treating CNS diseases

  • Authors: Ahmad, N., Khan, K., Rashid, H.U., Ullah, R., Ali, E.A.
  • Journal: Zeitschrift für Physikalische Chemie
  • Year: 2024
  • Volume: 238, Issue 8, Pages 1551–1577
  • Citations: 1

Direct synthesis, characterization, in vitro and in silico studies of simple chalcones as potential antimicrobial and antileishmanial agents

  • Authors: Ur Rashid, H., Khan, S., Irum, Shah, T., Khan, K.
  • Journal: Royal Society Open Science
  • Year: 2024
  • Volume: 11, Article 240410
  • Citations: 0

Homology modeling and molecular docking study of corticotrophin-releasing hormone: An approach to treat stress-related diseases

  • Authors: Ahmad, N., Khan, K., Khan, S.W., Ullah, R., Ali, E.A.
  • Journal: Open Chemistry
  • Year: 2024
  • Volume: 22, Article 20240069
  • Citations: 0

Biological investigations of Aspergillus ficuum via in vivo, in vitro and in silico analyses

  • Authors: Shah, Z.A., Khan, K., Shah, T., Muhammad, A., Rashid, H.
  • Journal: Scientific Reports
  • Year: 2023
  • Volume: 13, Article 17260
  • Citations: 1

Insights into metabolic and pharmacological profiling of Aspergillus ficuum through bioinformatics and experimental techniques

  • Authors: Shah, Z.A., Khan, K., Rashid, H.U., Jaremko, M., Iqbal, Z.
  • Journal: BMC Microbiology
  • Year: 2022
  • Volume: 22, Article 295
  • Citations: 4

Research Timeline

Dr. Khan’s research trajectory spans over a decade, beginning with his PhD studies from 2008 to 2013, followed by various research projects involving computational analyses and synthesis of organic compounds. His ongoing projects encompass a wide range of studies aimed at understanding and inhibiting viral proteins, particularly related to SARS-CoV-2 and other pathogenic viruses.

Collaborations and Projects

Dr. Khan has collaborated with both national and international researchers on diverse projects, enhancing the scope and impact of his research. These collaborations have resulted in joint publications and a collective effort to address significant challenges in medicinal chemistry and virology. His ability to work across disciplines and institutions underscores his commitment to collaborative scientific inquiry.

Conclusion

Dr. Khalid Khan’s recognition as a Best Researcher reflects his significant contributions to organic chemistry and medicinal research. His publication record and collaborative efforts enhance his impact within the scientific community. By addressing areas for improvement, such as increasing citation metrics and expanding research diversification, Dr. Khan can further strengthen his position as a leader in his field. His commitment to education and research not only benefits his students but also contributes to the broader scientific landscape, making his work essential for advancements in drug discovery and public health.